Acquired immunologic genetic variation in lupus pathogenesis and heterogeneity
Search Results
You searched for: lupus nephritis
Results found: 1112
Virtual transcriptome and proteome in lupus pathogenesis and heterogeneity
Research Roadmap
A bold research strategy to impact people living with lupus
In 2018, the Lupus Research Alliance (LRA) developed and adopted...
Webinars
Our webinars bring together leading experts, researchers, and community voices to share the latest developments in lupus research, treatment,...
ALCAM in Lupus
Potential New Treatment in Phase III Trial
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
Lupus Kidney Inflammation May Have Different Cause Than Commonly Believed
NEW YORK, NY. April 29. Lupus can harm many organs in the body, including the kidneys. A new study...
On “Lupus Call to Action Day”, the Lupus Research Alliance and Lupus Therapeutics Amplify a Call for Equity and Inclusion
As part of Lupus Awareness Month, May 1 has been declared “Lupus Call to Action Day” by the National...
PLK1, a potential novel therapeutic target for lupus
IDO2, a novel therapeutic target for the treatment of lupus
Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus
December 3, 2019
The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...
Lupus Research Alliance Launches New Philanthropic Fund to Advance Treatments and Diagnostics
The Fund Will be Managed by Experienced Life Sciences Investor Nishant Rastogi Today, the Lupus Research Alliance, the world’s...